Cigna Group Files 8-K for Financial Results

Ticker: CI · Form: 8-K · Filed: 2024-05-02T00:00:00.000Z

Sentiment: neutral

Topics: financial-results, 8-k

TL;DR

Cigna Group dropped its 8-K, check the financials.

AI Summary

On May 2, 2024, The Cigna Group filed an 8-K report detailing its financial results. The company, formerly known as Cigna Corp and Halfmoon Parent, Inc., is incorporated in Delaware and headquartered in Bloomfield, Connecticut.

Why It Matters

This filing provides investors with crucial updates on The Cigna Group's financial performance and condition, impacting investment decisions.

Risk Assessment

Risk Level: low — This is a routine financial filing (8-K) and does not inherently present new risks.

Key Players & Entities

FAQ

What is the purpose of this 8-K filing?

This 8-K filing is a Current Report filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting on the Results of Operations and Financial Condition, and Financial Statements and Exhibits.

When was this report filed?

The report was filed on May 2, 2024.

What is the principal business address of The Cigna Group?

The principal executive offices are located at 900 Cottage Grove Road, Bloomfield, Connecticut 06002.

What were the former names of The Cigna Group?

The company was formerly known as Cigna Corp and Halfmoon Parent, Inc.

What is the SIC code for The Cigna Group?

The Standard Industrial Classification code for The Cigna Group is 6324, which corresponds to HOSPITAL & MEDICAL SERVICE PLANS.

From the Filing

0000950159-24-000134.txt : 20240502 0000950159-24-000134.hdr.sgml : 20240502 20240502061515 ACCESSION NUMBER: 0000950159-24-000134 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240502 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240502 DATE AS OF CHANGE: 20240502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cigna Group CENTRAL INDEX KEY: 0001739940 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 824991898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38769 FILM NUMBER: 24905067 BUSINESS ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 BUSINESS PHONE: 8602266000 MAIL ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 FORMER COMPANY: FORMER CONFORMED NAME: Cigna Corp DATE OF NAME CHANGE: 20181221 FORMER COMPANY: FORMER CONFORMED NAME: Halfmoon Parent, Inc. DATE OF NAME CHANGE: 20180508 8-K 1 cigna8k.htm THE CIGNA GROUP FORM 8-K The Cigna Group Earnings 8-K false 0001739940 0001739940 2024-05-02 2024-05-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES   SECURITIES AND EXCHANGE COMMISSION   Washington, D.C. 20549   FORM 8-K     CURRENT REPORT   Pursuant to Section 13 or 15(d) of the   Securities Exchange Act of 1934   Date of Report (Date of earliest event reported) May 2, 2024   The Cigna Group   (Exact name of registrant as specified in its charter)   Delaware (State or other jurisdiction of   incorporation) 001-38769 (Commission File Number) 82-4991898 (IRS Employer Identification No.)   900 Cottage Grove Road Bloomfield , Connecticut 06002   (Address of principal executive offices) (Zip Code)   Registrant’s telephone number, including area code:   ( 860 ) 226-6000   Not Applicable   (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $0.01 CI New York Stock Exchange , Inc.   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐               Item 2.02 Results of Operations and Financial Condition.   On May 2, 2024, The Cigna Group issued a press release announcing results for the three months ended March 31, 2024. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.   The Evernorth Health Services reportable segment now presents the Pharmacy Benefit Services and the Specialty and Care Serv

View on Read The Filing